Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.7 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |